Edward Garmey MD, Alacrita Consultant, is lecturing at Harvard Medical School on June 23.

Edward's lecture, titled "Checkpoint inhibitors in the treatment of cancer" will present CPIs as a model for harnessing and enabling the body's immune system in the war against cancer.

The lecture is part of a course to introduce translational medicine to MD and PhD students and will specifically focus on the investigation of how unmet medical needs are identified and addressed.

For more information on how we can assist your biotech or pharmaceutical project, please reach out.

.custom-post-pagination {display: none;}